1. The global challenge of diabetes. Lancet 2008; 371: 1723PMID:
18502275.
2. Task Force Team for Basic Statistical Study of Korean Diabetes Mellitus. Report of Task Force Team for Basic Statistical Study of Korean Diabetes Mellitus: diabetes in Korea 2007. 2007, Seoul, Goldfishery. pp 14-21.
3. Kim DJ. The Epidemiology of diabetes in Korea. Diabetes Metab J 2011; 35: 303-308. PMID:
21977448.
4. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853. PMID:
9742976.
5. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004; 27(Suppl 1): S5-S10. PMID:
14693921.
6. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183-1197. PMID:
9203460.
7. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703-713. PMID:
9732337.
8. Hanefeld M, Temelkova-Kurktschiev T, Schaper F, Henkel E, Siegert G, Koehler C. Impaired fasting glucose is not a risk factor for atherosclerosis. Diabet Med 1999; 16: 212-218. PMID:
10227566.
9. DECODE Study Group. European Diabetes Epidemiology Group. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? Diabetes Care 2003; 26: 688-696. PMID:
12610023.
10. Halkos ME, Lattouf OM, Puskas JD, Kilgo P, Cooper WA, Morris CD, et al. Elevated preoperative hemoglobin A1c level is associated with reduced long-term survival after coronary artery bypass surgery. Ann Thorac Surg 2008; 86: 1431-1437. PMID:
19049726.
11. Marchant MH Jr, Viens NA, Cook C, Vail TP, Bolognesi MP. The impact of glycemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty. J Bone Joint Surg Am 2009; 91: 1621-1629. PMID:
19571084.
12. Bailey CJ, Turner RC. Metformin. N Engl J Med 1996; 334: 574-579. PMID:
8569826.
13. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 2012; 55: 1577-1596. PMID:
22526604.
14. Mahler RJ. Metformin: actions and indications for use in non-insulin-dependent diabetes mellitus. Endocr Pract 1995; 1: 418-422. PMID:
15251570.
15. Aguilar-Bryan L, Nichols CG, Wechsler SW, Clement JP 4th, Boyd AE 3rd, Gonzalez G, et al. Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion. Science 1995; 268: 423-426. PMID:
7716547.
16. Leibowitz G, Cerasi E. Sulphonylurea treatment of NIDDM patients with cardiovascular disease: a mixed blessing? Diabetologia 1996; 39: 503-514. PMID:
8739909.
17. Zoungas S, de Galan BE, Ninomiya T, Grobbee D, Hamet P, Heller S, et al. Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial. Diabetes Care 2009; 32: 2068-2074. PMID:
19651921.
18. Fuhlendorff J, Rorsman P, Kofod H, Brand CL, Rolin B, MacKay P, et al. Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes. Diabetes 1998; 47: 345-351. PMID:
9519738.
19. Yki-Jarvinen H. Thiazolidinediones. N Engl J Med 2004; 351: 1106-1118. PMID:
15356308.
20. Kahn SE, Haffner SM, Heise MA, Herman WH, Holman RR, Jones NP, et al. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 2006; 355: 2427-2443. PMID:
17145742.
21. Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi-Benedetti M, Moules IK, et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet 2005; 366: 1279-1289. PMID:
16214598.
22. Nesto RW, Bell D, Bonow RO, Fonseca V, Grundy SM, Horton ES, et al. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003. Circulation 2003; 108: 2941-2948. PMID:
14662691.
23. Chiasson JL, Josse RG, Hunt JA, Palmason C, Rodger NW, Ross SA, et al. The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial. Ann Intern Med 1994; 121: 928-935. PMID:
7734015.
24. Sheehan MT. Current therapeutic options in type 2 diabetes mellitus: a practical approach. Clin Med Res 2003; 1: 189-200. PMID:
15931309.
25. Kennedy L. Incretin-based therapies for type 2 diabetes mellitus: New therapeutic mechanisms. Cleve Clin J Med 2009; 76(Suppl 5): S2-S3. PMID:
19952299.
26. Drucker DJ. The biology of incretin hormones. Cell Metab 2006; 3: 153-165. PMID:
16517403.
27. Juhl CB, Hollingdal M, Sturis J, Jakobsen G, Agerso H, Veldhuis J, et al. Bedtime administration of NN2211, a long-acting GLP-1 derivative, substantially reduces fasting and postprandial glycemia in type 2 diabetes. Diabetes 2002; 51: 424-429. PMID:
11812750.
28. Amori RE, Lau J, Pittas AG. Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis. JAMA 2007; 298: 194-206. PMID:
17622601.
29. Deacon CF. Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: a comparative review. Diabetes Obes Metab 2011; 13: 7-18. PMID:
21114598.
30. Pratley RE, Salsali A. Inhibition of DPP-4: a new therapeutic approach for the treatment of type 2 diabetes. Curr Med Res Opin 2007; 23: 919-931. PMID:
17407649.
31. Wright DH, Herman GA, Maes A, Liu Q, Johnson-Levonas AO, Wagner JA. Multiple doses of sitagliptin, a selective DPP-4 inhibitor, do not meaningfully alter pharmacokinetics and pharmacodynamics of warfarin. J Clin Pharmacol 2009; 49: 1157-1167. PMID:
19783710.
32. Jabbour S. Primary care physicians and insulin initiation: multiple barriers, lack of knowledge or both? Int J Clin Pract 2008; 62: 845-847. PMID:
18479275.
33. Wyne KL, Mora PF. Insulin therapy in type 2 diabetes. Endocr Res 2007; 32: 71-107. PMID:
18092196.
34. Holleman F, Hoekstra JB. Insulin lispro. N Engl J Med 1997; 337: 176-183. PMID:
9219705.
35. Holman RR, Farmer AJ, Davies MJ, Levy JC, Darbyshire JL, Keenan JF, et al. Three-year efficacy of complex insulin regimens in type 2 diabetes. N Engl J Med 2009; 361: 1736-1747. PMID:
19850703.
36. Smith U, Gale EA. Does diabetes therapy influence the risk of cancer? Diabetologia 2009; 52: 1699-1708. PMID:
19597799.
37. Robertshaw HJ, Hall GM. Diabetes mellitus: anaesthetic management. Anaesthesia 2006; 61: 1187-1190. PMID:
17090240.
38. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997; 157: 2413-2446. PMID:
9385294.
39. Frisch A, Chandra P, Smiley D, Peng L, Rizzo M, Gatcliffe C, et al. Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgery. Diabetes Care 2010; 33: 1783-1788. PMID:
20435798.
40. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345: 1359-1367. PMID:
11794168.
41. Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA 2003; 290: 2041-2047. PMID:
14559958.
42. Hirsch IB, McGill JB, Cryer PE, White PF. Perioperative management of surgical patients with diabetes mellitus. Anesthesiology 1991; 74: 346-359. PMID:
1990909.
43. Ryan GJ, Jobe LJ, Martin R. Pramlintide in the treatment of type 1 and type 2 diabetes mellitus. Clin Ther 2005; 27: 1500-1512. PMID:
16330288.
44. Kang H, Ahn KJ, Choi JY, Park HJ, Park SJ, Lee SK. Efficacy of insulin glargine in perioperative glucose control in type 2 diabetic patients. Eur J Anaesthesiol 2009; 26: 666-670. PMID:
19367171.
45. Cure P, Pileggi A, Alejandro R. Exenatide and rare adverse events. N Engl J Med 2008; 358: 1969-1970. PMID:
18450614.